Pfizer-BioNTech seek U.S. OK for second COVID booster for 65 and older | Reuters
Pfizer Inc and its German partner BioNTech SE on Tuesday filed an application with U.S. regulators seeking emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older.